Erik Mogalian is a biopharmaceutical executive with deep experience across the entirety of R&D and through commercialization with specific expertise in translational & clinical development, product development, program leadership & strategy, and company leadership.
Erik is active in company and team building for emerging biotechnology companies and serves as an advisor to ARCH Venture Partners and other funds where he brings broad technical and operating experience.
Prior to focusing on early-stage companies, Erik held multiple senior leadership roles at Vir Biotechnology, including Senior Vice President of Product Development, Senior Vice President and Chief of Staff, Senior Vice President of Program Leadership, and Vice President of Clinical Pharmacology.
At Vir, Erik supported the development and execution of programs across infectious disease and immunology, including antibody and RNAi therapeutic programs, and led the team which was granted an Emergency Use Authorization for sotrovimab during the COVID-19 pandemic. Erik also supported company growth, including contributing to the IPO and managing multiple partnerships, leading to substantial revenue and value creation.
Before joining Vir, Erik spent more than a decade at Gilead Sciences in roles spanning formulation and process development, clinical pharmacology, and launch of small-molecule therapeutics for hepatitis C, hepatitis B, and HIV.
Earlier in his career, Erik worked as an acute care clinical pharmacist at Tucson Medical Center, giving him a patient-care and health-system foundation that complements his later work in pharmaceutical development and biotechnology leadership.
Erik has authored or co-authored peer-reviewed publications, including in the New England Journal of Medicine and Lancet. Erik also holds patent filings across multiple therapeutic and development areas across product and clinical development.
EDUCATION + CERTIFICATION
Pharm.D in Pharmacy from the University of Arizona.
Ph.D in Pharmaceutical Sciences from the University of Arizona.
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.